HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity.

Abstract
An increasing number of studies has indicated that hypoxic-ischemic-induced cerebral injury is partly mediated via oxidative stress. Recent researches have focused on searching for drug and herbal manipulations to protect against hypoxic-ischemic-induced oxidative cell damage. Scutellarin is a flavonoid derived from the Erigeron breviscapus (vant.) and has been reported to exhibit neuroprotective properties. However, its precise mechanism, particularly its antioxidation mechanism, remains elusive. In the present study, we investigated the neuroprotective effects of scutellarin on middle cerebral artery occlusion (MCAO)-induced brain damage in rats, and oxygen-glucose deprivation (OGD)-induced toxicity in primary culture of rat cortical neurons. In vivo, intraperitoneal injections of scutellarin (20 and 60 mg/kg) improved the neurological score and diminished the percentage of brain infarct volume. At the same time, scutellarin significantly increased superoxide dismutase (SOD), catalase (CAT) activities and glutathione (GSH) level in ischemic brain tissues, enhancing endogenous antioxidant activity. Moreover, pretreatment of scutellarin (25, 50 and 100 μM) protected neurons against lethal stimuli, decreased the percentage of apoptotic cells and inhibited reactive oxygen species (ROS) generation in OGD-induced primary cortical neurons in vitro. These results suggest that the preventive and therapeutic potential of scutellarin in cerebral injury patients is, at least in part, ascribed to augmentation of cellular antioxidant defense capacity.
AuthorsHong Guo, Li-Min Hu, Shao-Xia Wang, Yu-Lin Wang, Fang Shi, Hui Li, Yang Liu, Li-Yuan Kang, Xiu-Mei Gao
JournalThe Chinese journal of physiology (Chin J Physiol) Vol. 54 Issue 6 Pg. 399-405 (Dec 31 2011) ISSN: 0304-4920 [Print] India
PMID22229507 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Drugs, Chinese Herbal
  • Glucuronates
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • scutellarin
  • Apigenin
Topics
  • Animals
  • Antioxidants (metabolism)
  • Apigenin (chemistry, pharmacology)
  • Brain Infarction (drug therapy, metabolism)
  • Cerebral Cortex (cytology)
  • Drugs, Chinese Herbal (chemistry, pharmacology)
  • Glucuronates (chemistry, pharmacology)
  • Hypoxia-Ischemia, Brain (drug therapy, metabolism)
  • Infarction, Middle Cerebral Artery (drug therapy, metabolism)
  • Male
  • Neurons (cytology, drug effects, metabolism)
  • Neuroprotective Agents (chemistry, pharmacology)
  • Oxidative Stress (drug effects)
  • Primary Cell Culture
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: